In 2015, Ian Goldin, an Oxford University professor, warned in his book "The Butterfly Defect" about the risks of a global pandemic in a modern, interdependent world.
Mar 20, 2020
0
2
Most articles published between 2014 and 2019 discussing the characteristics, use, and therapeutic effect of cannabidiol (CBD) are supportive, with supportive conclusions in more studies with CBD-related industry funding, ...
Mar 17, 2020
0
0
A new book titled "Ending Parkinson's Disease: A Prescription for Action" and authored by University of Rochester Medical Center neurologist Ray Dorsey, M.D. and his colleagues, lays out a new vision to prevent, advocate ...
Mar 12, 2020
0
5
While firearm violence is a major public health challenge in the United States, it has often been considered a law enforcement issue with only law enforcement solutions. An article by two University of Pennsylvania researchers ...
Mar 9, 2020
1
1
Travel in the United States is safe and the economic hit from the coronavirus will be minimal, industry chiefs said Wednesday, even as cases of the virus multiply in the country.
Mar 4, 2020
0
1
Johns Hopkins Medicine researchers report that the number of disabled students admitted to U.S. medical schools rose from 2.9% to 4.9% over the last three years. However, the percentage of NIH-funded researchers with disabilities ...
Mar 4, 2020
0
2
With the outbreak of the novel coronavirus (2019-nCoV) in Wuhan, China, stories of courage and strength have captured our collective attention as the disease spreads.
Feb 13, 2020
1
2
The World Health Organization on Wednesday called for $675 million (613 million euros) in donations for a plan to fight the novel coronavirus, mainly through investment in countries considered particularly "at risk".
Feb 5, 2020
1
20
(HealthDay)—The United States spends substantially more than any other wealthy nation on health care, yet it has a lower life expectancy and a higher suicide rate than other wealthy nations, according to a January data ...
Jan 30, 2020
0
1
Industry funding of patient groups is common in many high income countries, but few patient groups have formal policies that govern corporate funding and financial transparency is inadequate, warn experts in The BMJ today.
Jan 22, 2020
0
2
